Connect with us

Technology

Grand Opening of the Second CREATE Symposium, Exploring New Directions in Smart Healthcare

Published

on

HONG KONG, Nov. 25, 2024 /PRNewswire/ — In an era driven by artificial intelligence (AI), the deep integration of advanced technologies into healthcare has become an unstoppable trend. These innovations are reshaping the industry, accelerating transformation, and driving unprecedented breakthroughs. From November 22 to 23, 2024, the 2nd Hong Kong Clinical-driven Robotics and Embodied AI TEchnology Symposium (CREATE Symposium), organized by the Centre for Artificial Intelligence and Robotics (CAIR) of Hong Kong Institute of Science and Innovation (HKISI), Chinese Academy of Sciences (CAS), opened grandly at the Charles K. Kao Auditorium, Hong Kong Science Park (HKSTP). The event received support from the Beijing-Hong Kong Exchange of Personnel Centre, the Hong Kong Top Talent Services Association (HKTTSA), the Hong Kong Information Technology Joint Council, and HKSTP Corporation. 

The symposium brought together leading global scholars and experts to explore the innovative application of medical technologies in clinical practice while showcasing breakthrough achievements like the “CARES Copilot 2.0,” a testament to the transformative impact of embodied intelligence on healthcare. Their presence elevated the event, reflecting its significance for the healthcare and technology sectors.

Opening Keynotes: Collaboration as the Key to Meaningful Innovation

The forum’s opening day featured a distinguished lineup of guests, including Mr. Albert Wong, CEO of the HKSTP Corporation; Dr. Kin-lai Chung, Cluster Chief Executive of New Territories East and Hospital Chief Executive of Prince of Wales Hospital; Dr. Yinxing Hao, Executive President of HKISI, CAS; Professor Kam-fai Wong, Member of the Legislative Council of the Hong Kong Special Administrative Region (HKSAR); Dr. Hailong Shang, Member of the Legislative Council of the HKSAR and Founder of the HKTTSA ; and Mr. Chang-lin Gao, General Manager of the Beijing-Hong Kong Exchange of Personnel Centre.

On the first day, more than 10 global experts and industry leaders engaged in in-depth discussions on the intersection of AI and healthcare. In his welcome speech, Professor Hongbin Liu, Director of CAIR, emphasized the importance of collaboration: ” The application of AI technology has permeated various aspects of healthcare, but meaningful breakthroughs require close collaboration among clinical practitioners, academic researchers, and industry professionals. Only through such a tripartite partnership can truly impactful innovation be achieved .”

Mr. Albert Wong highlighted Hong Kong’s strategic role in advancing healthcare innovation: “Artificial intelligence and robotics are profoundly reshaping healthcare. Leveraging its position as the core of the Greater Bay Area and the research strengths of its five globally top-ranked universities, Hong Kong has become a critical hub connecting Mainland China and the global market. Hong Kong Science Park will continue to foster cross-disciplinary collaboration to propel life and health technologies onto the global stage.”

Dr. Kin-lai Chung discussed AI’s transformative impact on healthcare: “From disease diagnosis and precision treatment to surgical assistance and rehabilitation support, AI and robotics are revolutionizing healthcare. Technological innovation is key to addressing rising healthcare demands, improving diagnostic accuracy, enhancing patient experiences, and alleviating the workload of healthcare professionals.”

Dr. Yinxing Hao underscored Hong Kong’s unique advantages: “With its blend of Eastern and Western cultures and global networks, Hong Kong is an ideal hub for attracting top-tier talent and driving technological breakthroughs. Strong government support for innovation and collaboration among universities, enterprises, and international institutions has laid a clear path for future development.”

Launch of “CARES Copilot 2.0”, A New Era in Smart Healthcare

During the forum, CAIR unveiled CARES Copilot 2.0, an intelligent healthcare solution developed to address clinical needs through cutting-edge technologies. This milestone marks a new era of smart healthcare, introducing four core upgrades that enhance the quality and efficiency of medical services:

MedSearch: Integrating natural language processing (NLP) and recommendation systems, this tool provides efficient medical search and content generation capabilities. It allows healthcare professionals to quickly retrieve and generate structured medical reports, improving clinical decision-making and ensuring access to the latest medical knowledge.MedKnow: Using knowledge graphs, this feature delivers intelligent medication recommendations, enabling multi-level queries about drug interactions, indications, and contraindications. With photo upload capabilities, it parses medication packaging or inserts via AI, generating accurate recommendations to enhance drug safety.Automated Surgical Report Generation System: Focused on respiratory system diagnostics, this system generates professional surgical reports quickly, integrating seamlessly into hospital information systems. It optimizes workflows and reduces the workload of healthcare professionals.Embodied Applications: Leveraging large language model technology, this feature combines digital human localization, robotic motion control, and 3D reconstruction to enable fully automated ultrasound examinations. It enhances accuracy and consistency, setting a new benchmark for intelligent healthcare.

Professor Hongbin Liu remarked: “CARES Copilot 2.0 is not just a technological innovation but a significant evolution for the healthcare industry. It empowers clinicians to achieve more efficient and accurate diagnoses while providing an enhanced medical experience for patients.”

Expert Insights: AI’s Transformative Role in Healthcare

The symposium brought together several world-renowned experts to discuss the deep integration of artificial intelligence with healthcare, sharing the latest research findings and practical experiences. Topics spanned technological innovation, clinical applications, and future development directions.

Professor Sebastien Ourselin, Fellow of the Royal Academy of Engineering and a professor at King’s College London, emphasized in his keynote speech that the success of innovative technologies depends not only on their advancement but also on their ability to integrate seamlessly into patient care pathways and achieve commercialization. He stressed that technology should serve healthcare needs rather than simply pursue breakthroughs for their own sake, and that solving clinical challenges is key to maximizing value.

Dr. Tat-Ming Danny Chan, Head of Division of Neurosurgery at the Department of Surgery, The Chinese University of Hong Kong (CUHK), illustrated the deep integration of artificial intelligence, augmented reality, and robotics in advancing embodied intelligence in surgical applications. Using neurosurgery as an example, he highlighted that the future of medicine lies not only in treating diseases but also in leveraging cutting-edge technologies to decode the mechanisms of the brain and body, breaking down barriers between humans and technology.

Professor Nassir Navab, a member of Academia Europaea and a Professor at Technical University of Munich, analyzed the challenges of surgical automation. He noted that, compared to autonomous driving, surgical automation requires a deeper understanding of anatomy and physiology and the ability to emulate the decision-making and thought processes of surgeons. He believes that future surgical robots will need to integrate multimodal data to enable truly intelligent surgical support.

Professor Jiebo Luo, Fellow of Academia Europaea and the US National Academy of Inventors and a professor at the University of Rochester, focused on the application of AI in medical imaging. He highlighted that deep learning has overcome the limitations of traditional manual feature design through automated feature extraction, driving medical imaging computation toward multimodal data integration and providing more precise decision-making support for clinical diagnosis.

Professor Feng Liu from the School of Electrical Engineering and Computer Science at the University of Queensland discussed the design of MRI systems, introducing mathematical and physical model-based design methods. He explored how theoretical platforms and engineering optimizations, combined with patient modeling and validation, are advancing MRI technology.

Other experts included Prof. Renzhi Wang, Consultant and Full Professor, School of Medicine Neuroimaging Center, Chinese University of Hongkong (Shenzhen) & Chief Physician and Professor of the Department of Neurosurgery, Peking Union Medical College Hospital; Prof. Xiaorong Ronald Xu, Professor and Doctoral Advisor at the Department of Precision Instrumentation and College of Biomedical Engineering at Suzhou Institute for Advanced Research, University of Science and Technology of China; Prof. Hongliang Ren, Professor at the Department of Electronic Engineering at CUHK; Prof. Ka-Wai Kwok from the Department of Mechanical and Automation Engineering,  CUHK; Prof. Hao Chen, Assistant Professor of the Department of Computer Science & Engineering and Department of Chemical & Biological Engineering, Hong Kong University of Science and Technology; and Prof. Qingpeng Zhang, Associate Professor at the Musketeers Foundation Institute of Data Science and the Department of Pharmacology and Pharmacy at The University of Hong Kong. They presented breakthroughs spanning basic research to clinical applications, covering areas such as medical imaging, surgical assistance, and drug development. Together, these insights demonstrated how AI is enabling comprehensive upgrades across the healthcare industry.

The CREATE Symposium seeks to promote interdisciplinary collaboration by harnessing the potential of intelligent technology to drive innovative breakthroughs in healthcare and enhance smart healthcare solutions. As we look ahead, artificial intelligence and robotics will play a crucial role in transforming medical models, providing fresh perspectives and solutions for the global healthcare landscape.

About CAIR

Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences is the first national-level R&D institution in Hong Kong approved by the central government. It is also directly affiliated with the Chinese Academy of Sciences. The Centre for Artificial Intelligence and Robotics (CAIR) is one of the two innovation centers under its umbrella. CAIR focuses on research in areas such as multimodal AI surgical models, embodied AI medical robots, and the fundamental theories of AI. The goal is to build Hong Kong into an artificial intelligence hub with national support, attract international high-end talents, and establish an international innovation hub for the applications of artificial intelligence and robotics in medical technology and life sciences.

For more information, please visit CAIR’s WeChat public account or the Center’s official website: https://www.cair-cas.org.hk

View original content:https://www.prnewswire.com/apac/news-releases/grand-opening-of-the-second-create-symposium-exploring-new-directions-in-smart-healthcare-302315238.html

SOURCE Centre for Artificial Intelligence and Robotics (CAIR), Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Bill Faust Named Consulting Magazine Top Consultant of the Year in Industry Specialization

Published

on

By

Impact Advisors Leader Recognized for Expertise in Healthcare IT Implementation

CHICAGO, April 22, 2026 /PRNewswire-PRWeb/ — Impact Advisors, a leading healthcare management consulting firm, is proud to announce that Bill Faust, Managing Director, has been named a Top Consultant of the Year by Consulting Magazine in the category of Industry Specialization. This prestigious award honors consultants who demonstrate deep domain expertise and deliver exceptional value to clients within their field.

“Bill’s recognition as a Top Consultant of the Year is a testament to his deep industry expertise and unwavering commitment to client success.” -Andy Smith, managing partner and co-founder of Impact Advisors

Faust brings more than 28 years of healthcare IT experience, with a distinguished track record leading large-scale, complex implementations for both ambulatory and acute care organizations. Over the past 25 years, he has held progressive leadership roles supporting major Epic and Oracle initiatives, helping healthcare systems successfully navigate digital transformation and achieve measurable outcomes.

In his role at Impact Advisors, Faust leads the firm’s EHR Implementation & Support practice, where he is responsible for driving strategy, delivery excellence, and client success across some of the most complex healthcare IT programs in the country. His ability to combine deep technical knowledge with strong executive communication has enabled him to build trusted relationships with clients and vendor partners alike.

“Bill’s recognition as a Top Consultant of the Year is a testament to his deep industry expertise and unwavering commitment to client success,” said Andy Smith, managing partner and co-founder of Impact Advisors. “He consistently delivers high-impact results for our clients while helping advance the healthcare industry through his thoughtful, strategic leadership. Bill joined our team as our ninth colleague, and we’re fortunate to have had his guidance for all these years.”

Consulting Magazine’s Top Consultants awards recognize outstanding professionals who have made significant contributions to the consulting profession and their clients. The Industry Specialization category specifically highlights consultants who have demonstrated exceptional depth of knowledge and impact within a defined sector.

Faust’s recognition underscores Impact Advisors’ continued leadership in healthcare consulting and its commitment to delivering innovative, high-quality solutions that improve patient care and operational performance.

About Impact Advisors

Impact Advisors is a leading healthcare management consulting firm offering a comprehensive suite of technology-enabled performance improvement solutions that deliver measurable and sustainable value for clients. Our commitment to excellence has earned Best in KLAS® recognition for 19 consecutive years, and our distinctive culture has been named a “Best Place to Work” by Modern Healthcare for 16 years. Learn more at www.impact-advisors.com.

Media Contact

Catherine Povalitis, Impact Advisors, 1 815-282-9976, cpovalitis@chartwellagency.com, https://www.impact-advisors.com/

View original content to download multimedia:https://www.prweb.com/releases/bill-faust-named-consulting-magazine-top-consultant-of-the-year-in-industry-specialization-302750670.html

SOURCE Impact Advisors

Continue Reading

Technology

Hewlett Foundation President: Philanthropy Must Bridge AI Governance Gap Between Washington and Silicon Valley

Published

on

By

Amber D. Miller makes the case for philanthropy and civil society to protect critical infrastructure and deliver broad benefits.

SAN FRANCISCO, April 22, 2026 /PRNewswire/ — As conversations between Washington and Silicon Valley about AI policy grow more contentious, Hewlett Foundation President Amber D. Miller calls on philanthropy to step up. In a new op-ed published by RealClearPolicy, Miller argues that governments and industry can’t close America’s AI governance gap alone, but independent institutions and philanthropy can help bridge the divide.

Drawing on her background as a physicist, Miller advocates for a practical, non-ideological approach to AI governance focused on protecting critical infrastructure, preventing strategic technological surprise, and keeping people safe while fostering innovation.

“Much of America’s critical infrastructure is highly distributed and deeply vulnerable, and its protection is dangerously under-resourced. The Hewlett Foundation wants to maximize the public benefits of emerging technologies while proactively mitigating their risks.”

To address these challenges, the Hewlett Foundation recently announced $10 million in exploratory grants to support the security of emerging technologies, including AI, biotechnology, and quantum computing.

Major grants were awarded to Stanford University’s Hoover Institution for its Tech Futures Lab, which focuses on anticipating technological surprises and enhancing U.S. resilience and Vanderbilt University’s Institute for National Security for its Wicked Problems Lab, which is building defenses against synthetic information warfare like deepfakes.

Former Secretary of State Condoleezza Rice, the director of the Hoover Institution, highlighted the importance of integrating security into innovation: “Innovation is key to national security…. Innovators will have more valuable, more marketable products if they build security into it at the front end.”

Other grantees include, the AI Now Institute, Aspen Institute, Atlantic Council, Carnegie Endowment for International Peace, Council on Foreign Relations, Georgetown University, Global Network Initiative, Institute for Security and Technology, Observer Research Foundation America, RAND, and Sentinel Bio.

Miller calls on others to join Hewlett, writing, “America has led every major technological era of the modern age, helping usher in significant discoveries that have benefited communities both here and around the world. Whether it continues to lead will depend not only on breakthroughs in labs, but on whether innovation earns public trust and delivers broad benefits. Philanthropy, with its long-term focus and commitment to charitable good, can do much to help.”

For more, read the op-ed and grant announcement: https://hewlett.org/americas-ai-governance-gap-needs-independent-oversight/ 

View original content to download multimedia:https://www.prnewswire.com/news-releases/hewlett-foundation-president-philanthropy-must-bridge-ai-governance-gap-between-washington-and-silicon-valley-302750841.html

SOURCE The Hewlett Foundation

Continue Reading

Technology

Hyperscale Data Sees Rising Demand Across Defense Portfolio Amid Heightened Global Activity

Published

on

By

LAS VEGAS, April 22, 2026 /PRNewswire/ — Hyperscale Data, Inc. (NYSE American: GPUS), an artificial intelligence (“AI”) data center company anchored by Bitcoin (“Hyperscale Data” or the “Company”), today announced that its wholly-owned subsidiary Gresham Worldwide, Inc., which is expected to be merged with another wholly owned subsidiary of the Company called Ballista Group, Inc., and the related party TurnOnGreen, Inc. (the “Defense Systems Group”), are actively supporting the expected increase in global defense production through its integrated portfolio of high-performance defense engineering and manufacturing subsidiaries.

The Defense Systems Group operates as an integrated engineering and manufacturing platform serving defense, aerospace, and industrial markets, delivering mission-critical electronics, radio frequency (“RF”) systems, power platforms, and advanced control technologies across the full lifecycle, from design through long-term sustainment. 

Recent global events, including but not limited to the ongoing conflicts in the Middle East and Ukraine, have contributed to increased demand signals across defense and mission-critical infrastructure supply chains. Management of the Defense Systems Group has observed a measurable uptick in inbound inquiries, program discussions and order flow across the group’s core product lines, particularly in:

RF and microwave systems supporting radar and electronic warfare;Power systems and ruggedized electronics for defense and mobility platforms; andTest, validation, and simulation technologies for mission-critical environments.

“These are environments where failure is not an option,” said Milton “Todd” Ault III, Executive Chairman of Hyperscale Data. He added that “The Defense Systems Group was assembled to deliver precision-engineered solutions for exactly these mission-critical applications, and we are seeing that demand accelerate in real time.” Further, Mr. Ault stated that “The group’s combination of deep engineering expertise, advanced manufacturing capabilities, and a global operational footprint provides a strong foundation to support long-term growth across defense, aerospace, and other mission-critical technology sectors.

The Defense Systems Group platform supports highly regulated and security-sensitive programs, operating under certifications including ISO, AS9100, and ITAR compliance, and serves customers across defense, aerospace, and critical infrastructure sectors globally. 

“As geopolitical conditions evolve, supply chains for advanced electronics and defense-related technologies are becoming increasingly constrained,” stated William Horne, Chief Executive Officer of Hyperscale Data. “The Defense Systems Group collectively provides a vertically integrated platform supporting advanced defense electronics, power systems, RF and microwave components, and precision-engineered subsystems, positioning the organization to support current and emerging demand across multiple strategic defense programs.”

While the Company continues to monitor global developments, management of the Defense Systems Group believes that sustained demand for mission-critical electronics, ruggedized power systems, and secure infrastructure technologies could present potential opportunities across the Defense Systems Group.

For more information on Hyperscale Data and its subsidiaries, Hyperscale Data recommends that stockholders, investors and any other interested parties read Hyperscale Data’s public filings and press releases available under the Investor Relations section at hyperscaledata.com or available at www.sec.gov.

About Hyperscale Data, Inc.

Through its wholly owned subsidiary Sentinum, Inc., Hyperscale Data owns and operates a data center at which it mines digital assets and offers colocation and hosting services for the emerging AI ecosystems and other industries. Hyperscale Data’s other wholly owned subsidiary, Ault Capital Group, Inc. (“ACG”), is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies with a global impact.

Hyperscale Data currently expects the divestiture of ACG (the “Divestiture”) to occur in the second quarter of 2027. Upon the occurrence of the Divestiture, the Company would be an owner and operator of data centers to support high-performance computing services, as well as a holder of the digital assets. Until the Divestiture occurs, the Company will continue to provide, through ACG and its wholly and majority-owned subsidiaries and strategic investments, mission-critical products that support a diverse range of industries, including an AI software platform, equipment rental services, defense/aerospace, industrial, automotive, medical/biopharma and hotel operations. In addition, ACG is actively engaged in private credit and structured finance through a licensed lending subsidiary. Hyperscale Data’s headquarters are located at 11411 Southern Highlands Parkway, Suite 190, Las Vegas, NV 89141.

On December 23, 2024, the Company issued one million (1,000,000) shares of a newly designated Series F Exchangeable Preferred Stock (the “Series F Preferred Stock”) to all common stockholders and holders of the Series C Preferred Stock on an as-converted basis. The Divestiture will occur through the voluntary exchange of the Series F Preferred Stock for shares of Class A Common Stock and Class B Common Stock of ACG (collectively, the “ACG Shares”). The Company reminds its stockholders that only those holders of the Series F Preferred Stock who agree to surrender such shares, and do not properly withdraw such surrender, in the exchange offer through which the Divestiture will occur, will be entitled to receive the ACG Shares and consequently be shareholders of ACG upon the occurrence of the Divestiture.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “believes,” “plans,” “anticipates,” “projects,” “estimates,” “expects,” “intends,” “strategy,” “future,” “opportunity,” “may,” “will,” “should,” “could,” “potential,” or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties.

Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect the Company’s business and financial results are included in the Company’s filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company’s Forms 10-K, 10-Q and 8-K. All filings are available at www.sec.gov and on the Company’s website at hyperscaledata.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hyperscale-data-sees-rising-demand-across-defense-portfolio-amid-heightened-global-activity-302750842.html

SOURCE Hyperscale Data Inc.

Continue Reading

Trending